Skip to content

LSD: all studies

Page 53 of 282: studies 521 to 530 of 2,815, newest first. Back to the LSD overview

Research

‘Hitting Highs at Rock Bottom’: LSD Treatment for Alcoholism, 1950–1970

Social History of Medicine July 17, 2006 Erika Dyck 87 citations

Journal Article ‘Hitting Highs at Rock Bottom’: LSD Treatment for Alcoholism, 1950–1970 Get access Erika Dyck Erika Dyck * *Department of History and Classics/Division of Studies for Medical Education, 2–2 Tory Building , University of Alberta , Edmonton, Alberta, T6G 2H4 , Canada . E-mail: Erika.dyck@ualberta.ca Search for other works by this author on: Oxford Academic PubMed Google Scholar...

Response of cluster headache to psilocybin and LSD

Neurology June 26, 2006 R. Andrew Sewell, John H. Halpern, Harrison G. Pope 259 citations

The authors interviewed 53 cluster headache patients who had used psilocybin or lysergic acid diethylamide (LSD) to treat their condition. Twenty-two of 26 psilocybin users reported that psilocybin aborted attacks; 25 of 48 psilocybin users and 7 of 8 LSD users reported cluster period termination; 18 of 19 psilocybin users and 4 of 5 LSD users reported remission period extension. Research on...

DOI: 10.1212/01.wnl.0000219761.05466.43 (opens in new tab) Ipilimumab Nivolumab Demographics Adverse effect +4

[100 years Albert Hofmann: LSD--miracle drug and problem child, Basel, January 13-15, 2006].

Psychiatrische Praxis May 1, 2006 Raoul M Hecker

Anlässlich des 100. Geburtstages des LSD-Drogen-Erfinders Albert Hofmann veranstaltete die Gaia Media Stiftung einen dreitägigen Kongress im Baseler Kongresszentrum. Insgesamt kamen über 1600 Besucher bei doch recht hohen Eintrittspreisen und 200 Pressevertreter zu der Tagung. Atmosphärisch interessant gestaltete sich schon der Vorraum des Zentrums, in dem psychonautische Klänge und eine...

DOI: 10.1055/s-2006-941627 (opens in new tab) Lysergic acid diethylamide Humans Hallucinogens History, 20th century +1

The 5-HT1A receptor and the stimulus effects of LSD in the rat.

Psychopharmacology October 2005 Chad J Reissig, Justin R Eckler, R A Rabin et al.

It has been suggested that the 5-HT1A receptor plays a significant modulatory role in the stimulus effects of the indoleamine hallucinogen lysergic acid diethylamide (LSD). The present study sought to characterize the effects of several compounds with known affinity for the 5-HT1A receptor on the discriminative stimulus effects of LSD. Twelve male Fischer 344 rats were trained in a two-lever,...

Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics.

Molecular Psychiatry September 1, 2005 P Seeman, F Ko, T Tallerico

Although phencyclidine and ketamine are used to model a hypoglutamate theory of schizophrenia, their selectivity for NMDA receptors has been questioned. To determine the affinities of phencyclidine, ketamine, dizocilpine and LSD for the functional high-affinity state of the dopamine D2 receptor, D2High, their dissociation constants (Ki) were obtained on [3H]domperidone binding to human cloned...

The stimulus properties of LSD in C57BL/6 mice.

Pharmacology, Biochemistry, and Behavior August 2005 Jerrold C Winter, A K Kieres, M D Zimmerman et al.

Drug-induced stimulus control has proven to be a powerful tool for the assessment of a wide range of psychoactive drugs. Although a variety of species has been employed, the majority of studies have been in the rat. However, with the development of techniques which permit the genetic modification of mice, the latter species has taken on new importance. Lysergic acid diethylamide [LSD], the...

LSD, Lying Ink, and Lies, Inc.

Science Fiction Studies July 1, 2005 Andrew M. Butler

Philip K. Dick has a reputation in some circles as an acid-crazed visionary, which was more the result of his self-publicity than his particular drug habits. During the 1960s he repeatedly discussed his LSD use in fanzine articles and letters, and he incorporated it as a plot device in a novel that was to become Lies, Inc. (1983). The textual history of this novel, and its precursor version,...

Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.

Psychopharmacology July 2005 Danuta Marona‐lewicka, Ronald A Thisted, David E Nichols

The effect of LSD in humans has been described as occurring in two temporal phases. The behavioral effects in rats also occur in two temporal phases: an initial suppression of exploration followed by increased locomotor activity. We decided to investigate this phenomenon from the perspective that the pharmacology might have relevance to the neurochemical mechanisms underlying psychosis....

Flashback: psychiatric experimentation with LSD in historical perspective.

The Canadian Journal of Psychiatry June 1, 2005 Erika Dyck 88 citations

In the popular mind, d-lysergic acid diethylamide (LSD) research in psychiatry has long been associated with the CIA-funded experiments conducted by Ewen Cameron at the Allen Memorial Institute in Montreal, Quebec. Despite this reputation, a host of medical researchers in the post World War II era explored LSD for its potential therapeutic value. Some of the most widespread trials in the...

Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex

Neuropsychopharmacology March 9, 2005 Paul J Gresch, Randy L Smith, Robert J. Barrett et al. 62 citations

Tolerance is defined as a decrease in responsiveness to a drug after repeated administration. Tolerance to the behavioral effects of hallucinogens occurs in humans and animals. In this study, we used drug discrimination to establish a behavioral model of lysergic acid diethylamide (LSD) tolerance and examined whether tolerance to the stimulus properties of LSD is related to altered serotonin...